FT announces increase in EU prices for Moderna and Pfizer vaccines

The American companies Pfizer and Moderna have raised the cost of their coronavirus vaccines for the European Union, the Financial Times (FT) writes, citing supply contracts.

According to the newspaper, Pfizer has raised the price of its vaccine by more than a quarter. The new price per dose of the drug was €19.50 compared to €15.5 previously. Moderna increased the cost by more than a tenth. In the latest EU supply contracts, Moderna is priced at $25.50. In the first purchase deal, according to the FT interlocutors, one dose cost about $22.60.

The terms of the deals were renegotiated after data from Phase 3 trials showed that Pfizer's and Moderna's mRNA-based vaccines are more effective than cheaper vaccines developed by ASTRAZENECA and Johnson & Johnson.

The companies expect to generate "tens of billions of dollars" in revenue this year as buyer countries race to secure supplies amid the spread of the more contagious delta strain of the coronavirus, the FT writes.